Difficulty: Medium
Average Score: 91%
Practice
The Yellow Card Scheme:
Correct answer
C
Rationale
The correct answer is C) Allows patients to report suspected adverse reactions.
The Yellow Card Scheme is a UK initiative that allows patients, healthcare professionals, and caregivers to report suspected adverse reactions to medications, vaccines, herbal products, and medical devices. This reporting system helps regulatory authorities monitor the safety of healthcare products post-marketing.
Option A is incorrect because reports submitted to the Yellow Card Scheme are actually entered into a database operated by the Medicines and Healthcare products Regulatory Agency (MHRA), not the Health and Safety Executive (HSE).
Option B is incorrect because the Yellow Card Scheme is applicable to all medications and vaccines, regardless of whether they have Black Triangle status or not.
Option D is incorrect because the Yellow Card Scheme encourages reporting of all suspected adverse reactions, not just serious ones. It is important to report even minor or common reactions to get a comprehensive understanding of a product's safety profile.
Educationally, understanding the Yellow Card Scheme is crucial for healthcare professionals as it promotes pharmacovigilance and patient safety. Reporting adverse reactions helps identify previously unknown side effects, monitor drug safety trends, and ultimately protect public health. Healthcare providers should encourage patients to report any suspected adverse reactions they experience to contribute to a safer healthcare system.
The Yellow Card Scheme is a UK initiative that allows patients, healthcare professionals, and caregivers to report suspected adverse reactions to medications, vaccines, herbal products, and medical devices. This reporting system helps regulatory authorities monitor the safety of healthcare products post-marketing.
Option A is incorrect because reports submitted to the Yellow Card Scheme are actually entered into a database operated by the Medicines and Healthcare products Regulatory Agency (MHRA), not the Health and Safety Executive (HSE).
Option B is incorrect because the Yellow Card Scheme is applicable to all medications and vaccines, regardless of whether they have Black Triangle status or not.
Option D is incorrect because the Yellow Card Scheme encourages reporting of all suspected adverse reactions, not just serious ones. It is important to report even minor or common reactions to get a comprehensive understanding of a product's safety profile.
Educationally, understanding the Yellow Card Scheme is crucial for healthcare professionals as it promotes pharmacovigilance and patient safety. Reporting adverse reactions helps identify previously unknown side effects, monitor drug safety trends, and ultimately protect public health. Healthcare providers should encourage patients to report any suspected adverse reactions they experience to contribute to a safer healthcare system.